People have been cautioned by the World Health Organization and US pharmaceutical company; Eli Lilly to be cautious of counterfeit versions of well-known diabetes and weight loss medications.
The active component of Novo Nordisk’s Wegovy and Ozempic, phony semaglutide, has been reported to the WHO in every part of the globe since 2022, the organization said on Thursday.
In an open letter, Lilly stated that it was “extremely concerned” about rising social media posts and online sales of fraudulent or synthetic forms of tirzepatide, the active component in the medications Zepbound and Mounjaro.
According to the Indianapolis-based business, tirzepatide is not supplied to internet merchants, wellness centers, compounding pharmacies, or any other legal supplier of those medications.
Lilly claimed that using phony copies of its medications, which are regularly promoted or sold online, is never safe. Similar cautions regarding Novo Nordisk’s medications have been issued in the past.
According to the WHO, patients who use medicines from authorized physicians can safeguard themselves. The organization advised patients not to purchase the medications from unidentified vendors.
According to Lilly, any goods sold under the brand names tirzepatide rather than Mounjaro or Zepbound were not created by the pharmaceutical company and did not have US FDA approval.
Gentle Reminder: Be careful how you use your authority and influence, be wise, and treat others with respect.
Chychy Jonas
